BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Seongil Jo

Seongil Jo appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
Applicationsmath.STMethodologyStatistics Theory

Catalog footprint

What is connected

3works
4topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Estimation of World Seroprevalence of SARS-CoV-2 antibodies

In this paper, we estimate the seroprevalence against COVID-19 by country and derive the seroprevalence over the world. To estimate seroprevalence, we use serological surveys (also called the serosurveys) conducted within each country. When the serosurveys are incorporated to estimate world seroprevalence, there are two issues. First, there are countries in which a serological survey has not been conducted. Second, the sample collection dates differ from country to country. We attempt to tackle these problems using the vaccination data, confirmed cases data, and national statistics. We construct Bayesian models to estimate the numbers of people who have antibodies produced by infection or vaccination separately. For the number of people with antibodies due to infection, we develop a hierarchical model for combining the information included in both confirmed cases data and national statistics. At the same time, we propose regression models to estimate missing values in the vaccination data. As of 31st of July 2021, using the proposed methods, we obtain the 95% credible interval of the world seroprevalence as [38.6%, 59.2%].

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Seroprevalence of SARS-CoV-2 antibodies in South Korea

In $2020$, Korea Disease Control and Prevention Agency reported three rounds of surveys on seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in South Korea. We analyze the seroprevalence surveys using a Bayesian method with an informative prior distribution on the seroprevalence parameter, and the sensitivity and specificity of the diagnostic test. We construct the informative prior using the posterior distribution obtained from the clinical evaluation data based on the plaque reduction neutralization test. The constraint of the seroprevalence parameter induced from the known confirmed coronavirus 2019 cases can be imposed naturally in the proposed Bayesian model. We also prove that the confidence interval of the seroprevalence parameter based on the Rao's test can be the empty set, while the Bayesian method renders a reasonable interval estimator. As of the $30$th of October $2020$, the $95\%$ credible interval of the estimated SARS-CoV-2 positive population does not exceed $307,448$, approximately $0.6\%$ of the Korean population.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

The Beta-Mixture Shrinkage Prior for Sparse Covariances with Posterior Minimax Rates

Statistical inference for sparse covariance matrices is crucial to reveal dependence structure of large multivariate data sets, but lacks scalable and theoretically supported Bayesian methods. In this paper, we propose beta-mixture shrinkage prior, computationally more efficient than the spike and slab prior, for sparse covariance matrices and establish its minimax optimality in high-dimensional settings. The proposed prior consists of beta-mixture shrinkage and gamma priors for off-diagonal and diagonal entries, respectively. To ensure positive definiteness of the resulting covariance matrix, we further restrict the support of the prior to a subspace of positive definite matrices. We obtain the posterior convergence rate of the induced posterior under the Frobenius norm and establish a minimax lower bound for sparse covariance matrices. The class of sparse covariance matrices for the minimax lower bound considered in this paper is controlled by the number of nonzero off-diagonal elements and has more intuitive appeal than those appeared in the literature. The obtained posterior convergence rate coincides with the minimax lower bound unless the true covariance matrix is extremely sparse. In the simulation study, we show that the proposed method is computationally more efficient than competitors, while achieving comparable performance. Advantages of the shrinkage prior are demonstrated based on two real data sets.

0 citations0 reviewsNo code linkedOpen access